| Active ingredient (INN) | Plerixafor |
|---|---|
| Brand names | MOZOBIL plerixafor |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | AFT Pharmaceuticals Pty Ltd, Sanofi-Aventis Australia Pty Ltd, Sagent Pharmaceuticals, Camber Pharmaceuticals, Inc. +2 more |
| Registrations on file | 10 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Arx | 24 mg | — | 🇦🇺 AU | — | Active |
| Eugia | 24 mg | — | 🇦🇺 AU | — | Active |
| Eug | 24 mg | — | 🇦🇺 AU | — | Active |
| Epsl | 24 mg | — | 🇦🇺 AU | — | Active |
| Aft | 24 mg | — | 🇦🇺 AU | AFT Pharmaceuticals Pty Ltd | Active |
| MOZOBIL plerixafor | 20 mg | — | 🇦🇺 AU | Sanofi-Aventis Australia Pty Ltd | Active |
| Plerixafor | 20mg/mL | injection | 🇺🇸 US | Sagent Pharmaceuticals | Active |
| Plerixafor | 24mg/1.2mL | injection | 🇺🇸 US | Camber Pharmaceuticals, Inc. | Active |
| Plerixafor Accord | — | — | 🌐 EU | Accord Healthcare S.L.U. | Active |
| PLERIXAFOR INJECTION | — | solution | 🇨🇦 CA | JAMP PHARMA CORPORATION | Active |